Paul J. Clancy, Executive VP and CFO at BIOGEN IDEC INC. (BIIB), sold 20,244 shares at $112.69 ($2.3M) on 2012-01-03, disclosed to the SEC on 2012-01-04.
Scheduled sale ($2.3M) by Executive VP and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $112.22 | 14,670 | $1.6M | 72.4% |
| 2 | $112.69 | 5,574 | $628K | 27.6% |
| Total | $112.35 avg | 20,244 | $2.3M | 100% |
| Filing → |
| ALXN | SELL | 2018-02-08 | $1.4M | — | Filing → |
| BIIB | SELL | 2017-04-27 | $2.9M | — | Filing → |
| BIIB | SELL | 2017-03-14 | $5.8M | — | Filing → |